The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.
Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.
A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.
Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.
Lymphomas are blood cancers that start in the cells of the immune system. Burkitt’s lymphoma is a particularly aggressive form of the disease. New research may have discovered a better way to treat it.
Mantle cell lymphoma is a rare, but aggressive form of blood cancer. It’s a form of non-Hodgkin lymphoma. Patients with this disease got a new treatment option today.
Pregnancy is such an exciting time in a woman’s life. She’s caring for herself and the child growing inside her. Sometimes, but not often, this bliss is interrupted with a cancer diagnosis. A recent study looked at treating blood cancers during pregnancy.
Non-Hodgkin lymphoma is a term that covers various types of blood cancers that develop in the lymphatic system. Researchers recently set out to see if replacing these cancerous cells with healthy ones could help improve survival.
During your doctor visits, there are some things you may not want to bring up. You may think they’re concerns your doctor can't help you with, or maybe you’re embarrassed to talk about them. Recent research looked at what topics cancer patients are willing to discuss with their doctors.